Table 1.
Baseline and clinical characteristics of the patients (n = 142)
| Characteristics | Number (n = 1) | % |
|---|---|---|
| Age(years) | ||
| < 60 | 91 | 64.1 |
| ≥ 60 | 51 | 35.9 |
| KPS score | ||
| 70–80 | 20 | 14.1 |
| 90–100 | 122 | 85.9 |
| Histology | ||
| Epithelial carcinoma | 132 | 93.0 |
| Serous | 101 | 71.17 |
| Endometrial | 12 | 8.45 |
| Clear cell carcinoma | 13 | 9.15 |
| Others | 6 | 4.23 |
| Interstitial tumors of the sex cords | 6 | 4.2 |
| Germ cell tumors | 4 | 2.8 |
| FIGO stage | ||
| I | 12 | 8.5 |
| II | 13 | 9.2 |
| III | 102 | 71.7 |
| IV | 15 | 10.6 |
| Recurrence/metastasis times | ||
| < 2 | 84 | 59.2 |
| ≥ 2 | 58 | 40.8 |
| Time to the last treatment | ||
| < 6 months | 35 | 24.6 |
| ≥ 6 months | 107 | 75.4 |
| Platinum sensitive station | ||
| PFI ≥ 6 months | 20 | 14.1 |
| PFI < 6 months | 122 | 85.9 |
| Recurrence/metastasis lesion | ||
| Single lesion | 67 | 47.2 |
| 2 lesions | 51 | 35.9 |
| 3–5 lesions | 24 | 16.9 |
| Recurrence/metastasis lesion | ||
| Visceral organ | 13 | 9.2 |
| Non visceral organ | 129 | 90.8 |
| Prior treatment | ||
| Operation | 142 | 100 |
| Chemotherapy | 142 | 100 |
| Immune therapy | 20 | 14.08 |
| Target therapy | 24 | 16.90 |
FIGO international federation of gynecologists and obstetrics, PFI platinum-free interval, RT radiation therapy